UroGen Pharma(URGN) - 2024 Q4 - Earnings Call Transcript

UroGen Pharma (URGN) Q4 2024 Earnings Call March 10, 2025 06:16 PM ET Company Participants Vincent Perrone - Senior Director of Investor RelationsLiz Barrett - President & CEOMark Schoenberg - Chief Medical OfficerDavid Lin - Chief Commercial OfficerChris Degnan - CFORaghuram Selvaraju - Managing Director, Healthcare Equity Research Conference Call Participants None - AnalystMichael Schmidt - Senior Managing Director & Equity Research Analyst - BiotechnologyLeland Gershell - MD & Senior Biotechnology Analys ...